You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent malignant lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Recurrent/Refractory Malignant Lymphoma Trial in Beijing (JS004 , Recombinant humanized IgG4k mAb specific to BTLA for injection

    Recruiting
    • Recurrent/Refractory Malignant Lymphoma
    • JS004 , Recombinant humanized IgG4k monoclonal antibody specific to BTLA for injection Intravenous infusion
    • Drugļ¼šJS001, Intravenous infusion
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Apr 13, 2022

    Collecting Blood and Tissue Sample Donations for Research for

    Not yet recruiting
    • Anal Carcinoma
    • +11 more
    • Biospecimen Collection
    • (no location specified)
    Dec 21, 2022

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Lymphoma, B-Cell, Leukemia, B-cell, Leukemia, T-Cell Trial in Cangzhou (CAR-T)

      Recruiting
      • Lymphoma, B-Cell
      • +3 more
      • CAR-T
      • Cangzhou, Hebei, China
        Cangzhou People's Hospital
      Nov 9, 2022

      Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Malignant Tumor in the CNS, Recurrent Diffuse Intrinsic Pontine Glioma Trial

      Active, not recruiting
      • Diffuse Midline Glioma, H3 K27M-Mutant
      • +10 more
      • FACT Complex-targeting Curaxin CBL0137
      • Birmingham, Alabama
      • +19 more
      Jun 29, 2022

      Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

      Completed
      Has Results
      • Brain Stem Neoplasm
      • +9 more
      • Birmingham, Alabama
      • +20 more
      Jan 6, 2023

      Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

      Active, not recruiting
      Has Results
      • Recurrent Lymphoma
      • +5 more
      • Birmingham, Alabama
      • +19 more
      Oct 20, 2022

      Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

      Recruiting
      • Colorectal Carcinoma
      • +21 more
      • Dual X-ray Absorptiometry
      • +2 more
      • Birmingham, Alabama
      • +18 more
      Jan 30, 2023

      Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

      Active, not recruiting
      Has Results
      • Metastatic Melanoma
      • +22 more
      • Ipilimumab
      • +3 more
      • Birmingham, Alabama
      • +24 more
      Jan 19, 2023

      Malignant Lymphoma Trial in Tianjin (Toripalimab)

      Completed
      • Malignant Lymphoma
      • Toripalimab
      • Tianjin, Tianjin, China
        Blood Diseases Hospital, Chinese Academy of Medical Sciences
      Sep 28, 2020

      Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,

      Withdrawn
      • Constitutional Mismatch Repair Deficiency Syndrome
      • +11 more
      • Biospecimen Collection
      • +2 more
      • Palo Alto, California
      • +8 more
      Sep 9, 2022

      Frequency of Cachexia in Ambulatory Cancer Patients and

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +6 more
      • Questionnaire Administration
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 1, 2021

      Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

      Terminated
      Has Results
      • Hematopoietic and Lymphoid Cell Neoplasm
      • +12 more
      • Laboratory Biomarker Analysis
      • ROR1 CAR-specific Autologous T-Lymphocytes
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 11, 2022

      Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

      Completed
      • Ependymoma
      • +9 more
      • Nivolumab
      • NKTR-214
      • Little Rock, Arkansas
      • +17 more
      Dec 8, 2022

      Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma Trial in United States (Elimusertib)

      Recruiting
      • Recurrent Alveolar Rhabdomyosarcoma
      • +7 more
      • Birmingham, Alabama
      • +28 more
      Jan 26, 2023

      Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +35 more
      • Birmingham, Alabama
      • +108 more
      Oct 19, 2022

      AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

      Recruiting
      • AIDS-Related Non-Hodgkin Lymphoma
      • +29 more
      • Laboratory Biomarker Analysis
      • Pembrolizumab
      • Birmingham, Alabama
      • +12 more
      Aug 4, 2022

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +32 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Birmingham, Alabama
      • +124 more
      Aug 24, 2022

      Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +31 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Birmingham, Alabama
      • +118 more
      Jan 27, 2023

      Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +30 more
      • Larotrectinib Sulfate
      • Birmingham, Alabama
      • +123 more
      Aug 23, 2022

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +35 more
      • Birmingham, Alabama
      • +113 more
      Jun 28, 2022

      Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

      Recruiting
      • Malignant Solid Neoplasm
      • +26 more
      • Birmingham, Alabama
      • +121 more
      Aug 24, 2022

      T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • CD7 CAR-T cells
      • Shenzhen, Guangdong, China
        Li Yu
      Nov 11, 2022

      Relapsed or Refractory Non-Hodgkin's Lymphoma, Relapsed or Refractory Multiple Myeloma Trial in Changsha (BEBT-908 for

      Completed
      • Relapsed or Refractory Non-Hodgkin's Lymphoma
      • Relapsed or Refractory Multiple Myeloma
      • BEBT-908 for injection
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Oct 9, 2023